Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Pharmacology, Healthy Volunteer Study”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01766167
What this trial is testing

Clinical Pharmacology Study of MP-424

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 26
Early research (Phase 1)Study completedNCT02624557
What this trial is testing

Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 23
Early research (Phase 1)Study completedNCT05898984
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 69
Early research (Phase 1)Study completedNCT05248945
What this trial is testing

DDI Study of Evobrutinib and Carbamazepine

Who this might be right for
Healthy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 14
Early research (Phase 1)Ended earlyNCT04322253
What this trial is testing

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose in Participants With Liver Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Pharmacology, Clinical
Bayer 22
Early research (Phase 1)Study completedNCT05064488
What this trial is testing

Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates

Who this might be right for
Healthy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 40
Early research (Phase 1)Study completedNCT06482346
What this trial is testing

Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers

Who this might be right for
Healthy Adult Male Volunteers
Tanabe Pharma Corporation 56
Not applicableStudy completedNCT00823407
What this trial is testing

Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

Who this might be right for
Healthy
California Pacific Medical Center Research Institute 12
Early research (Phase 1)Study completedNCT02633696
What this trial is testing

Study to Investigate the Absolute Bioavailability of Oral Sylibin

Who this might be right for
Healthy Volunteers
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 8
Early research (Phase 1)Ended earlyNCT04320771
What this trial is testing

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Pharmacology, Clinical
Bayer 18
Early research (Phase 1)Ended earlyNCT05280717
What this trial is testing

Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)

Who this might be right for
Covid19
Vir Biotechnology, Inc. 316
Early research (Phase 1)Ended earlyNCT02873650
What this trial is testing

Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 5
Early research (Phase 1)Study completedNCT03282513
What this trial is testing

AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Agios Pharmaceuticals, Inc. 33
Early research (Phase 1)Study completedNCT01009216
What this trial is testing

ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid

Who this might be right for
Healthy
Abbott 12
Early research (Phase 1)Study completedNCT04708847
What this trial is testing

A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer

Who this might be right for
Healthy Volunteers
Chugai Pharmaceutical 30
Early research (Phase 1)Study completedNCT02746237
What this trial is testing

Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585

Who this might be right for
Pulmonary Arterial Hypertension
Karos Pharmaceuticals 120
Early research (Phase 1)Study completedNCT01835561
What this trial is testing

Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males

Who this might be right for
Clinical Pharmacology, Healthy Volunteer Study
Celgene 32
Early research (Phase 1)Study completedNCT02743013
What this trial is testing

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers

Who this might be right for
COPD
Chiesi Farmaceutici S.p.A. 50
Early research (Phase 1)Study completedNCT02218671
What this trial is testing

Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 10
Not applicableStudy completedNCT00628121
What this trial is testing

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

Who this might be right for
Premenopause
Nippon Kayaku Co., Ltd. 31
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation